Rezolute, Inc. (RZLT)
4.02
+0.15
(+3.88%)
USD |
NASDAQ |
Nov 10, 16:00
4.015
0.00 (0.00%)
After-Hours: 20:00
Rezolute Total Assets (Quarterly) : 96.01M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.01M |
| June 30, 2026 | 112.85M |
| March 31, 2026 | 125.46M |
| December 31, 2025 | 138.63M |
| September 30, 2025 | 158.66M |
| June 30, 2025 | 175.49M |
| March 31, 2025 | 94.74M |
| December 31, 2024 | 112.01M |
| September 30, 2024 | 123.41M |
| June 30, 2024 | 132.74M |
| March 31, 2024 | 87.74M |
| December 31, 2023 | 102.15M |
| September 30, 2023 | 113.00M |
| June 30, 2023 | 123.72M |
| March 31, 2023 | 134.20M |
| December 31, 2022 | 150.21M |
| September 30, 2022 | 155.99M |
| June 30, 2022 | 152.42M |
| March 31, 2022 | 69.57M |
| December 31, 2021 | 83.40M |
| September 30, 2021 | 38.76M |
| June 30, 2021 | 42.61M |
| March 31, 2021 | 32.93M |
| December 31, 2020 | 38.90M |
| September 30, 2020 | 7.41M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.96M |
| March 31, 2020 | 14.70M |
| December 31, 2019 | 20.56M |
| September 30, 2019 | 26.57M |
| June 30, 2019 | 12.25M |
| March 31, 2019 | 15.46M |
| December 31, 2018 | 0.4557M |
| September 30, 2018 | 1.069M |
| June 30, 2018 | 2.503M |
| March 31, 2018 | 5.141M |
| December 31, 2017 | 6.322M |
| September 30, 2017 | 9.797M |
| June 30, 2017 | 10.63M |
| March 31, 2017 | 10.80M |
| December 31, 2016 | 9.938M |
| September 30, 2016 | 10.06M |
| June 30, 2016 | 10.90M |
| March 31, 2016 | 8.791M |
| December 31, 2015 | 8.534M |
| September 30, 2015 | 9.170M |
| June 30, 2015 | 11.26M |
| March 31, 2015 | 12.06M |
| December 31, 2014 | 10.72M |
| September 30, 2014 | 6.267M |
| June 30, 2014 | 7.405M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Opus Genetics, Inc. | 95.30M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.06M |
| Shareholders Equity (Quarterly) | 85.95M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.916 |
| Net Debt Paydown Yield | 0.04% |